Bausch+Lomb Results Presentation Deck

Reconciliation of Reported Revenue to Organic Revenue ¹,2 and Organic Revenue Growth 1.2 ($M) (4Q22 and FY22) Bausch+Lomb Vision Care Surgical Ophthalmic Pharmaceuticals Total Bausch + Lomb Bausch + Lomb Vision Care Surgical Ophthalmic Pharmaceuticals Total Bausch + Lomb BAUSCH + LOMB 1. 2. 3. Revenue as Reported 626 188 182 996 Revenue as Reported 2,373 718 677 3,768 Calculation of Organic Revenue for the Three Months Ended December 31, 2022 December 31, 2021 Changes in Exchange Rates ³ 32 14 8 54 Changes in Exchange Rates ³ Organic Revenue (Non- GAAP) ¹,² 114 44 26 184 658 202 190 1,050 Organic Revenue (Non- GAAP) 1,2 Revenue as Reported (3) Calculation of Organic Revenue for the Twelve Months Ended December 31, 2022 December 31, 2021 2,487 762 703 3,952 626 198 177 1,001 Revenue as Reported Divestitures and Discontinuations 2,343 718 704 3,765 (3) Divestitures and Discontinuations (10) (10) Organic Revenue (Non- GAAP) 1,2 626 195 177 998 Organic Revenue (Non- GAAP)1,2 2,343 708 704 3,755 Change in Reported Revenue Amount (10) 5 (5) Amount Change in Reported Revenue 30 Pct. (27) 3 0% -5% 3% 0% Pct. 1% 0% -4% 0% Change in Organic Revenue Amount 32 7 13 52 Amount Change in Organic Revenue 144 54 (1) 197 Pct. This is a non-GAAP measure or non-GAAP ratio. See Slide 2 and Non-GAAP Appendix for further information on non-GAAP measures and ratios. Organic revenue growth/change, a non-GAAP ratio, is defined as a change on a period-over-period basis in revenues on a constant currency basis (if applicable) excluding the impact of acquisitions, divestitures and discontinuations. The impact for changes in foreign currency exchange rates is determined as the difference in the current period reported revenues at their current period currency exchange rates and the current period reported revenues revalued using the monthly average currency exchange rates during the comparable prior period. 5% 4% 7% 5% Pct. 6% 8% 0% 5% 1,2 1,2 38

View entire presentation